Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

48-Week Efficacy and Safety of Dolutegravir Relative to Commonly Used Third Agents in Treatment-Naive HIV-1–Infected Patients: A Systematic Review and Network Meta-Analysis

Table 3

Difference (95% CrI) between direct clinical trial data and indirect model estimates.

Table 3

doi: https://doi.org/10.1371/journal.pone.0105653.t003